Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Jun 18, 2024 2:39pm
70 Views
Post# 36094477

RE:RE:If Medipharm continues to improve QOQ

RE:RE:If Medipharm continues to improve QOQand therein lies the conundrum for shareholders QC1

Management has publicly stated they believe the current market cap of Medipharm is very undervalued, yet short of quarterly required disclosure they are relatively selective with any positive announcements even though from the outside looking in, it would appear there are a lot of moving parts that could be promoted as positive events to shareholders.

Something as simple as including an approx monetary expectation from the Hope facility, as that will when sold add $$$ to the treasury.   Got to be worth something considering the price VIVO paid for Canna Farms a few short years ago.

I have no plans on selling my holdings with Labs as they appear to be steering the ship towards profitability, but there is no question it has been a frustrating ride the past few years especially when considering the huge global playing field to promote Medipharm specific medical products.

I like your thoughts of $2-3 QC1              Cheers to positive vibes for management meeting projections and expectations as we are not the only ones who see Labs as currently undervalued  :-)


https://www.theglobeandmail.com/investing/markets/stocks/LABS-T/pressreleases/26716372/medipharm-labs-top-10-undervalued-drug-manufacturers-industry-stocks-labs/


<< Previous
Bullboard Posts
Next >>